Business News • PR NewsWire • QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA and RNA Biomarkers in Common Cancers

QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA and RNA Biomarkers in Common Cancers

QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA and RNA Biomarkers in Common Cancers

HILDEN, Germany, and GERMANTOWN, Maryland, May 30, 2014 /PRNewswire/ -- Fourth oncology project with Lilly expands QIAGEN's Personalized Healthcare pipeline Development of modular assay panels focuses on multiple biomarkers targeting cellular pathways associated with innovative...

View More : http://www.prnewswire.com/news-releases/qiagen-and-lilly-collaborate-to-co-develop-companion-diagnostics-for-simultaneou...

Releted News by prnewswire

Cloud Connect China 2014 to launch the 1st Top Cloud Connect Awards

Market Forecasts on China Basic Passenger Vehicle and Bus Industries